AI-supported mammography increases breast cancer detection, reduces interval cancers, and substantially lowers radiologist workload versus standard double reading.
Key Details
- 1MASAI trial assigned 105,915 women to AI-assisted or double-reading groups in screening.
- 2AI-assisted mammography decreased interval cancer rate by 12% (1.55 vs. 1.76 per 1,000 women).
- 3Sensitivity was higher for AI (80.5%) compared to double reading (73.8%), with specificity unchanged (98.5% both groups).
- 4AI support resulted in a 44% reduction in screen-reading workload and a 29% increase in cancer detection without increasing false positives.
- 5Improvements were consistent across age and breast density, but not for in-situ cancers.
- 6The study highlights significant relevance amid a shortage of breast radiologists.
Why It Matters
These large-scale findings support integrating AI into breast cancer screening workflows for both higher detection rates and better efficiency, critical as radiology faces workforce challenges. Evidence from randomized trials will influence adoption, reimbursement, and future research.
Source
AuntMinnie
Related News
•Radiology Business
GE HealthCare and RadNet Expand Global AI Mammography Partnership
GE HealthCare and RadNet are extending their partnership globally to offer AI-enhanced mammography systems.
•Radiology Business
NCCN Endorses AI Risk Tools for Breast Cancer Screening
NCCN's 2026 guidelines recommend routine integration of AI-based 5-year breast cancer risk prediction from mammograms.
•AuntMinnie
FDA Rejects Petition to Exempt Radiology AI Devices from 510(k) Review
FDA denies a petition to exempt certain radiology AI software from 510(k) review, stressing ongoing regulatory oversight.